SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-21-006702
Filing Date
2021-03-01
Accepted
2021-03-01 17:25:30
Documents
7
Period of Report
2021-03-01

Document Format Files

Seq Description Document Type Size
1 6-K brhc10021079_6k.htm 6-K 15036
2 EXHIBIT 5.1 brhc10021079_ex5-1.htm EX-5.1 83950
3 EXHIBIT 5.2 brhc10021079_ex5-2.htm EX-5.2 14977
4 EXHIBIT 99.1 brhc10021079_ex99-1.htm EX-99.1 201207
5 image0.jpg GRAPHIC 22861
6 image00003.jpg GRAPHIC 4391
7 logo1.jpg GRAPHIC 2743
  Complete submission text file 0001140361-21-006702.txt   357848
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 21699607
SIC: 2834 Pharmaceutical Preparations